[HTML][HTML] Management of neuropsychiatric systemic lupus erythematosus: current approaches and future perspectives

C Magro-Checa, EJ Zirkzee, TW Huizinga… - Drugs, 2016 - Springer
Neuropsychiatric systemic lupus erythematosus (NPSLE) is a generic definition referring to
a series of neurological and psychiatric symptoms directly related to systemic lupus …

[HTML][HTML] Translating pharmacogenomics: challenges on the road to the clinic

JJ Swen, TW Huizinga, H Gelderblom… - PLoS …, 2007 - journals.plos.org
Pharmacogenomics is one of the first clinical applications of the postgenomic era. It promises
personalized medicine rather than the established “one size fits all” approach to drugs and …

Immunogenetics of rheumatoid arthritis: understanding functional implications

TC Messemaker, TW Huizinga, F Kurreeman - Journal of autoimmunity, 2015 - Elsevier
The last decade has seen a dramatic technological revolution. The characterisation of the
majority of the common variations in our genetic code in 2003 precipitated the discovery of the …

[PDF][PDF] Gene-gene and gene-environment interactions involving HLA-DRB1, PTPN22, and smoking in two subsets of rheumatoid arthritis

…, REM Toes, TW Huizinga… - The American Journal of …, 2007 - cell.com
Gene-gene and gene-environment interactions are key features in the development of
rheumatoid arthritis (RA) and other complex diseases. The aim of this study was to use and …

[PDF][PDF] Validation of a novel multibiomarker test to assess rheumatoid arthritis disease activity

…, R Knevel, TW Huizinga… - Arthritis care & …, 2012 - Wiley Online Library
Huizinga has received consultant fees (less than $10,000) from Crescendo Bioscience. Drs.
Haney, Shen, Ramanujan, Chernoff, and Ford own stock and/or stock options in Crescendo …

TLR‐mediated STAT 3 and ERK activation controls IL‐10 secretion by human B cells

BS Liu, Y Cao, TW Huizinga, DA Hafler… - European journal of …, 2014 - Wiley Online Library
IL ‐10‐producing B cells have a regulatory effect in various mouse models for immune‐mediated
disorders via secretion of IL ‐10, a potent immunoregulatory cytokine. However, …

Tumour necrosis factor alpha gene polymorphisms in rheumatoid arthritis: association with susceptibility to, or severity of, disease?

BM Brinkman, TW Huizinga, SS Kurban… - British journal of …, 1997 - academic.oup.com
Genetic factors associated with rheumatoid arthritis (RA) might involve variant tumour
necrosis factor (TNF)-alpha genes. Therefore, polymorphisms at positions -308, -238, -376, -163 …

MOR103, a human monoclonal antibody to granulocyte–macrophage colony-stimulating factor, in the treatment of patients with moderate rheumatoid arthritis: results …

…, R Stoilov, P Wiland, TW Huizinga… - Annals of the …, 2015 - ard.bmj.com
Objectives To determine the safety, tolerability and signs of efficacy of MOR103, a human
monoclonal antibody to granulocyte–macrophage colony-stimulating factor (GM-CSF), in …

Soluble Fc gamma receptor III in human plasma originates from release by neutrophils.

TW Huizinga, M de Haas, M Kleijer… - The Journal of …, 1990 - Am Soc Clin Investig
FcRIII (the CD16-antigen), a low affinity receptor for IgG, is expressed by neutrophils, natural
killer lymphocytes, and macrophages. We have developed a sensitive radioimmunoassay …

Biallelic neutrophil Na-antigen system is associated with a polymorphism on the phospho-inositol-linked Fc gamma receptor III (CD16)

TW Huizinga, M Kleijer, PA Tetteroo, D Roos… - 1990 - ashpublications.org
Neutrophils express two distinct types of receptor for the Fc region of IgG, FcRII and FcRIII, in
amounts of 10,000 to 20,000 FcRII (40 Kd) and 100,000 to 200,000 FcRIII (50 to 80 Kd) per …